Krutmann J - Search Results

1

High-dose UVA1 therapy in the treatment of patients with atopic dermatitis.

Krutmann J, Czech W, Diepgen T, Niedner R, Kapp A, Schöpf E. Krutmann J, et al. J Am Acad Dermatol. 1992 Feb;26(2 Pt 1):225-30. doi: 10.1016/0190-9622(92)70031-a. J Am Acad Dermatol. 1992. PMID: 1552057 Clinical Trial.

2

Ultraviolet radiation effects on human keratinocyte ICAM-1 expression: UV-induced inhibition of cytokine-induced ICAM-1 mRNA expression is transient, differentially restored for IFN gamma versus TNF alpha, and followed by ICAM-1 induction via a TNF alpha-like pathway.

Krutmann J, Czech W, Parlow F, Trefzer U, Kapp A, Schöpf E, Luger TA. Krutmann J, et al. J Invest Dermatol. 1992 Jun;98(6):923-8. doi: 10.1111/1523-1747.ep12460737. J Invest Dermatol. 1992. PMID: 1350607 Free article.

3

Human epidermal keratinocytes are a source of soluble ICAM-1 molecules.

Budnik A, Trefzer U, Parlow F, Grewe M, Kapp A, Schöpf E, Krutmann J. Budnik A, et al. Among authors: krutmann j. Exp Dermatol. 1992 Jul;1(1):27-30. doi: 10.1111/j.1600-0625.1992.tb00068.x. Exp Dermatol. 1992. PMID: 1364253

4

High-dose-UVA1 phototherapy: a novel and highly effective approach for the treatment of acute exacerbation of atopic dermatitis.

Krutmann J, Schöpf E. Krutmann J, et al. Acta Derm Venereol Suppl (Stockh). 1992;176:120-2. Acta Derm Venereol Suppl (Stockh). 1992. PMID: 1476022 Review.

5

Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis.

Czech W, Krutmann J, Schöpf E, Kapp A. Czech W, et al. Among authors: krutmann j. Br J Dermatol. 1992 Apr;126(4):351-5. doi: 10.1111/j.1365-2133.1992.tb00677.x. Br J Dermatol. 1992. PMID: 1571256

6

[The epidermal Langerhans cell: watch post of the immune system in relation to the outside world].

Simon JC, Krutmann J, Czech W, Kapp A, Schöpf E. Simon JC, et al. Among authors: krutmann j. Hautarzt. 1992 Apr;43(4):241-9. Hautarzt. 1992. PMID: 1597377 German. No abstract available.

7

55-kd tumor necrosis factor receptor is expressed by human keratinocytes and plays a pivotal role in regulation of human keratinocyte ICAM-1 expression.

Trefzer U, Brockhaus M, Loetscher H, Parlow F, Kapp A, Schöpf E, Krutmann J. Trefzer U, et al. Among authors: krutmann j. J Invest Dermatol. 1991 Nov;97(5):911-6. doi: 10.1111/1523-1747.ep12491668. J Invest Dermatol. 1991. PMID: 1680933 Free article.

8

Production of interleukin-2 by mononuclear cells in vitro in patients with atopic dermatitis and psoriasis. Comparison with serum interleukin-2 receptor levels.

Kapp A, Neuner P, Krutmann J, Luger TA, Schöpf E. Kapp A, et al. Among authors: krutmann j. Acta Derm Venereol. 1991;71(5):403-6. Acta Derm Venereol. 1991. PMID: 1684468

9

[New aspects of UV-therapy of atopic dermatitis].

Krutmann J, Schöpf E. Krutmann J, et al. Hautarzt. 1991 May;42(5):284-8. Hautarzt. 1991. PMID: 1874616 Review. German.

10

Tumor necrosis factor beta and ultraviolet radiation are potent regulators of human keratinocyte ICAM-1 expression.

Krutmann J, Köck A, Schauer E, Parlow F, Möller A, Kapp A, Förster E, Schöpf E, Luger TA. Krutmann J, et al. J Invest Dermatol. 1990 Aug;95(2):127-31. doi: 10.1111/1523-1747.ep12477839. J Invest Dermatol. 1990. PMID: 1974275 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

412 results

Search Page

Filters